Vimarsana
Biggest News Aggregation in the World

Page 2 - Bioscript Solutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bioscript Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bioscript Solutions Today - Breaking & Trending Today

NeonMind Biosciences Inc.: NeonMind and BioScript Solutions Announce Strategic Partnership Expanding NeonMind's Specialty Clinic Network for Interventional Psychiatry Treatments - Vimarsana News

NeonMind Biosciences Inc.: NeonMind and BioScript Solutions Announce Strategic Partnership Expanding NeonMind's Specialty Clinic Network for Interventional Psychiatry Treatments

VANCOUVER, BC / ACCESSWIRE / March 3, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind' or the "Company"), an integrated drug development and wellness company focused on bringing

Canada's Best Managed Companies demonstrate resilience to thrive, despite challenging year - Vimarsana News

Canada's Best Managed Companies demonstrate resilience to thrive, despite challenging year

/CNW/ - Deloitte Canada is thrilled to announce the winners of the 2021 Canada's Best Managed Companies awards program, spotlighting the top privately-owned...

BioScript Solutions® named one of Canada's Best Managed Companies - Vimarsana News

BioScript Solutions® named one of Canada's Best Managed Companies

Share this article MONCTON, NB, May 5, 2021 /CNW/ - BioScript Solutions ® is pleased to announce today that it has been recognized as one of Canada's Best Managed Companies. As one of the 2021 Best Managed Companies award winners, BioScript Solutions   is placed among the country's leading Canadian owned and managed companies with innovative, world-class business practices.  Co-founded in 2001 by pharmacists David Ford and Andrew Steeves, BioScript Solutions specializes in helping people achieve the best possible health outcomes by providing access to specialty drug therapies and ful...